Iqirvo Tablet, Film Coated
Product Images NDC 15054-0080

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Iqirvo (NDC 15054-0080). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Ipsen Biopharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Chemical Structure (Elafibranor 01)

Chemical Structure (Elafibranor 01)
Chemical structure of elafibranor shown in a skeletal formula diagram. The structure includes a substituted benzene ring, ketone groups, and a carboxylic acid moiety.*
FDA Label Image

Figure 1 (Elafibranor 02)

Figure 1 (Elafibranor 02)
A line graph comparing alkaline phosphatase (ALP) levels (U/L) over 52 weeks between IQIRVO and placebo groups. The x-axis represents time in weeks (0, 4, 13, 26, 39, 52), and the y-axis shows ALP levels from 100 to 450 U/L. IQIRVO group exhibits a notable decrease in ALP levels, while placebo levels remain relatively stable. Error bars indicate 95% confidence intervals for mean values.*
FDA Label Image

Principal Display Panel (80 mg Tablet Bottle Carton)

Principal Display Panel (80 mg Tablet Bottle Carton)
IQIRVO 80 mg tablets carton label for oral use, containing elafibranor. The packaging indicates 30 tablets per container and is manufactured for Ipsen Biopharmaceuticals, Inc. Storage instructions and child resistance warnings are included, along with a barcode and trademark details. The label features a white background with purple and blue accents.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.